HeartSciences (HSCSW) Notes Payables (2022 - 2026)

HeartSciences has reported Notes Payables for 5 years, with the latest figure at $3.1 million in Q1 2026.

• For the quarter ending Q1 2026, Notes Payables rose 22.7% year-over-year to $3.1 million; the trailing twelve-month figure through Jan 2026 stood at $3.1 million (up 22.7% YoY), and the FY2025 full-year result was $2.6 million, up 410.23% from the prior year.
• Notes Payables for Q1 2026 stood at $3.1 million, up from $500000.0 in the prior quarter.
• The five-year high for Notes Payables was $3.1 million in Q1 2026, with the low at $130000.0 in Q3 2022.
• Historically, Notes Payables has averaged $1.3 million across 5 years, with a median of $1.1 million in 2022.
• The largest YoY upside for Notes Payables was 410.23% in 2025 against a maximum downside of 78.87% in 2025.
• HeartSciences' Notes Payables stood at $1.1 million in 2022, then increased by 25.41% to $1.4 million in 2023, then surged by 67.01% to $2.4 million in 2024, then plunged by 78.87% to $500000.0 in 2025, then surged by 519.94% to $3.1 million in 2026.
• The last three Notes Payables figures came in at $3.1 million (Q1 2026), $500000.0 (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.